Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Mirati Therapeutics, Inc. (MRTX)

« Back to company index

MRTX Chatter Timeline

Stock Ticker for MRTX

Most Active Tweeters for MRTX

UserTweets
@FlashAlert_me 12
@InsiderAlerts4U 11
@A1Syad 6
@invescent 4
@formwhisperscom 4

Recent Tweets for MRTX

Jarvis_Alerts @Jarvis_Alerts
$MRTX 130C Exp:18-Mar-22 ? ? <R> Total(Day): $58,000 #UnusualActivity Sign-up free for beta ver.:… https://t.co/OMzPrexXKX
January 25th 2022, 10:01pm
StckPro @StckPro
$MRTX NEW ARTICLE : JMP Securities Reaffirms Their Hold Rating on Mirati Therapeutics (MRTX)… https://t.co/HSyn1rsAKn
January 25th 2022, 6:01am
LuciusJameson @LuciusJameson
RT @MarcJacksonLA: $MRTX $AMGN Mirati's adagrasib spurs 41% response in pancreatic, GI tumors, scoring points where KRAS leader Amgen hasn'…
January 24th 2022, 9:01pm
Tickeron @Tickeron
$MRTX enters a Downtrend because Momentum Indicator dropped below the 0 level on January 4, 2022. View odds for thi… https://t.co/K2XWJcJfkb
January 22nd 2022, 9:01pm
newsfilterio @newsfilterio
$171,203.25 of shares sold by Cherrington Julie M (Director), reported in a new form 4 filed with the SEC $MRTX https://t.co/gIrixoQvSo
January 22nd 2022, 1:01am
MarcJacksonLA @MarcJacksonLA
$MRTX $AMGN Mirati's adagrasib spurs 41% response in pancreatic, GI tumors, scoring points where KRAS leader Amgen… https://t.co/ZoIaTQaJil
January 21st 2022, 10:01pm
MarcJacksonLA @MarcJacksonLA
$MRTX Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-… https://t.co/oTn9Dy7hvM
January 21st 2022, 8:01pm
Gambiste1 @Gambiste1
RT @liangc_science: Wow KRAS G12C inhibitor achieved 50% ORR in last line PDAC! Hopefully Mirati $MRTX can deliver their YE 2021 IND promis…
January 21st 2022, 8:01pm
liangc_science @liangc_science
Wow KRAS G12C inhibitor achieved 50% ORR in last line PDAC! Hopefully Mirati $MRTX can deliver their YE 2021 IND pr… https://t.co/3xgwn2bWyA
January 21st 2022, 7:01pm
stock_patterns @stock_patterns
$MRTX - Pattern Detected ? Green line shows the recent price movements Red lines shows the similar price movements https://t.co/ndUbQEODuc
January 21st 2022, 7:01pm
newsfilterio @newsfilterio
Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients $MRTX https://t.co/U39l0kPrVY
January 21st 2022, 5:01pm
StckPro @StckPro
$MRTX NEW ARTICLE : Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients… https://t.co/fmYSl412jg
January 21st 2022, 5:01pm
Briefingcom @Briefingcom
$MRTX: Mirati Therapeutics presents results from Phase 2 cohort of KRYSTAL-1 study of adagrasib https://t.co/pOqzHMk88O
January 21st 2022, 5:01pm
newsinthemarket @newsinthemarket
Mirati Therapeutics presents results from Phase 2 cohort of KRYSTAL-1 study $MRTX
January 21st 2022, 3:01pm
HealthcareNinj1 @HealthcareNinj1
yay $MRTX https://t.co/Rd525iGInl
January 21st 2022, 3:01pm
FlashAlert_me @FlashAlert_me
$MRTX [15s. delayed]: Issued Press Release on January 21, 10:00:00: Mirati Therapeutics Presents Positive Clinical… https://t.co/kdUlyl8ads
January 21st 2022, 3:01pm
MSollender @MSollender
$MRTX In evaluable patients with pancreatic cancer (n=10), the response rate (RR) was 50%, including 1 unconfirmed partial response (PR)
January 21st 2022, 3:01pm
MSollender @MSollender
$MRTX Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-… https://t.co/2sbxdWin8v
January 21st 2022, 3:01pm
StockNewsBot2 @StockNewsBot2
$MRTX Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-… https://t.co/n2Ke2jeAv2
January 21st 2022, 3:01pm
TheTradeXchange @TheTradeXchange
$MRTX: Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C… https://t.co/F739peG6DL
January 21st 2022, 3:01pm
HammerstoneMar3 @HammerstoneMar3
$MRTX Mirati Therapeutics presents positive clinical data with investigational adagrasib in patients with krasg12c-… https://t.co/HAp1j7Fz5i
January 21st 2022, 3:01pm
hephaistos_ai @hephaistos_ai
RT @stock_titan: $MRTX Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-Mutated…
January 21st 2022, 3:01pm
stock_titan @stock_titan
$MRTX Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-… https://t.co/7XDTksZiN7
January 21st 2022, 3:01pm
WebChronicleTo1 @WebChronicleTo1
$MRTX Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-… https://t.co/BfjTzJyD2j
January 21st 2022, 3:01pm
InsiderAlerts4U @InsiderAlerts4U
$MRTX: New Insider Filing on Mirati Therapeutics, Inc.'s Director JULIE M CHERRINGTON: https://t.co/GDNhhT2wRc
January 21st 2022, 1:01pm
Ba4Saso @Ba4Saso
$MRTX Day Trading Ideas | Profit Factor of 26 and trade profitability of 77.78%9 trades executed and buy signal in… https://t.co/ZSE5dQNSbE
January 21st 2022, 1:01pm
invescent @invescent
$MRTX Data indicates that the overall analyst sentiment for MRTX is bullish. Simplify the way you research stock… https://t.co/WAt0hLAWjs
January 21st 2022, 5:01am
ShortAlgoTrades @ShortAlgoTrades
$MRTX Look at this! Profit Factor of 26 and trade profitability of 77.78%9 trades executed and buy signal in plac… https://t.co/3EbZ6ADx89
January 21st 2022, 4:01am
formwhisperscom @formwhisperscom
#FWSells $MRTX Cherrington Julie M, Director of Mirati Therapeutics, Inc. sold 1,475 shares on 2022-01-19. https://t.co/pRzBOwiube
January 21st 2022, 4:01am
InsiderForms @InsiderForms
$MRTX Insider Cherrington Julie M has Sold 1,475 Shares. Title :Director Total Cost: $171,203.25 Buy/Sell : Sell (… https://t.co/p8HAkHfUvk
January 20th 2022, 10:01pm
FlashAlert_me @FlashAlert_me
$MRTX [15s. delayed] filed SEC form 4: Director Cherrington Julie M: Disposed 1,475 of Common Stock at price $116.… https://t.co/PgV7J1J3mh
January 20th 2022, 9:01pm
MaiteMerenda @MaiteMerenda
$MRTX Bullish pattern forming. Chart by https://t.co/t5kOjgsWN3 https://t.co/uZqYHNovuw
January 20th 2022, 6:01pm
insidersanalyt1 @insidersanalyt1
on 2022-01-18 $MRTX insiders' SOLD 4304 securities equal to 0.01% of outstanding shares. Please follow and share if… https://t.co/MdSyF5975B
January 20th 2022, 5:01pm
A1Syad @A1Syad
$MRTX Awaiting Buy Signal. Chart by https://t.co/1MjnDHV7ua https://t.co/TfwQxdJYm8
January 20th 2022, 1:01pm
A1Syad @A1Syad
$MRTX Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/GOUPNEq4MP
January 20th 2022, 3:01am
SweepCastApp @SweepCastApp
$MRTX Mirati Therapeutics Option Alert: Jun 17 $150 Calls Sweep (11) near the Ask: 50 vs 174 OI; Earnings 2/24 Afte… https://t.co/zJCOBO1RW3
January 20th 2022, 3:01am
42Stocks @42Stocks
https://t.co/lYfUoKwu31 2022-01-19 7:20 PM $MRTX #MiratiTx Mirati Therapeutics up 4.16% = $285.53 million gain.… https://t.co/OKJemkZvkk
January 20th 2022, 12:01am
datadili @datadili
Mirati Therapeutics, Inc. traded 6.83% above it's 52-wk low as of 1:01PM EST $MRTX
January 19th 2022, 6:01pm
Tickeron @Tickeron
$MRTX enters a Downtrend as Momentum Indicator dropped below the 0 level on January 4, 2022. View odds for this and… https://t.co/3MPtQH6jxK
January 19th 2022, 1:01pm
Tickeron @Tickeron
Do you agree with the A.I. prediction? $MRTX RSI Indicator left the oversold zone. #MiratiTherapeutics… https://t.co/llId4PjuID
January 19th 2022, 1:01pm
InsiderAlerts4U @InsiderAlerts4U
$MRTX: New Insider Filing on Mirati Therapeutics, Inc.'s 10%+ Owner DAVIS AARON I.: https://t.co/Qv9OjJCi9C
January 19th 2022, 4:01am
InsiderAlerts4U @InsiderAlerts4U
$MRTX: New Insider Filing on Mirati Therapeutics, Inc.'s EVP, Chief Scientific Officer JAMIE CHRISTENSEN: https://t.co/mPGDBoJl9w
January 19th 2022, 4:01am
InsiderAlerts4U @InsiderAlerts4U
$MRTX: New Insider Filing on Mirati Therapeutics, Inc.'s SVP, Chief Accounting Officer VICKIE S REED: https://t.co/cqTtJZNynA
January 19th 2022, 4:01am
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in MIRATI THERAPEUTICS INC. COMM $MRTX https://t.co/XjEkP6SOKl
January 19th 2022, 2:01am
InsiderAlerts4U @InsiderAlerts4U
$MRTX: New Insider Filing on Mirati Therapeutics, Inc.'s Director JULIE M CHERRINGTON: https://t.co/1wAg6oNrtO
January 19th 2022, 2:01am
InsiderAlerts4U @InsiderAlerts4U
$MRTX: New Insider Filing on Mirati Therapeutics, Inc.'s Director BRUCE L A CARTER: https://t.co/0IPmY8Q8Ho
January 19th 2022, 1:01am
FlashAlert_me @FlashAlert_me
$MRTX [15s. delayed] filed SEC form 4: SVP, Chief Accounting Officer REED VICKIE S: Disposed 533 of Common Stock… https://t.co/0Z24uAOCKS
January 19th 2022, 1:01am
day_trading_de @day_trading_de
MRTX (Mirati Therapeutics, Inc.) ? #Insider #stock alert! ? #Sale on 2022-01-14 - $MRTX ??: BAUM CHARLES M (Preside… https://t.co/8agWW97sap
January 19th 2022, 1:01am
FlashAlert_me @FlashAlert_me
$MRTX [15s. delayed] filed SEC form 4: Director Hasnain Faheem: Granted 3,619 of Common Stock at price $0 on 2022-… https://t.co/SALhcxMg62
January 19th 2022, 1:01am
formwhisperscom @formwhisperscom
#FWSells $MRTX BAUM CHARLES M, President,Founder,Head of R&D of Mirati Therapeutics, Inc. sold 2,517 shares on 2022… https://t.co/cntrn3RDf0
January 19th 2022, 1:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.